Zydus Lifesciences reports 38% net profit growth in Q2
market hours1 source ↓written by the desknot a recommendation
- YoY for Q2
- 38% increase
- from operations rose
- 15% to ₹6,123 crore
- Formulations business contributing
- ₹2,744 crore
- margin expanded
- 32.96%
Zydus Lifesciences announced a net profit of ₹1,259 crore, a 38% increase YoY for Q2 FY26. Revenue from operations rose 15% to ₹6,123 crore, with the US Formulations business contributing ₹2,744 crore. The EBITDA margin expanded to 32.96%, indicating strong operational performance. 📈
This robust growth may enhance investor sentiment and trading activity in the pharma sector.
Not investment advice. For informational purposes only.